GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Establishment Labs Holdings Inc (NAS:ESTA) » Definitions » Beneish M-Score

Establishment Labs Holdings (Establishment Labs Holdings) Beneish M-Score : -1.91 (As of May. 26, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Establishment Labs Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.91 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Establishment Labs Holdings's Beneish M-Score or its related term are showing as below:

ESTA' s Beneish M-Score Range Over the Past 10 Years
Min: -3.35   Med: -2.62   Max: -1.41
Current: -1.91

During the past 8 years, the highest Beneish M-Score of Establishment Labs Holdings was -1.41. The lowest was -3.35. And the median was -2.62.


Establishment Labs Holdings Beneish M-Score Historical Data

The historical data trend for Establishment Labs Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Establishment Labs Holdings Beneish M-Score Chart

Establishment Labs Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial -2.87 -3.35 -2.49 -2.31 -1.72

Establishment Labs Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.15 -1.59 -1.41 -1.72 -1.91

Competitive Comparison of Establishment Labs Holdings's Beneish M-Score

For the Medical Devices subindustry, Establishment Labs Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Establishment Labs Holdings's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Establishment Labs Holdings's Beneish M-Score falls into.



Establishment Labs Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Establishment Labs Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.3496+0.528 * 1.0124+0.404 * 1.6586+0.892 * 0.9177+0.115 * 1.1468
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.19+4.679 * -0.002521-0.327 * 0.7552
=-1.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was $50.8 Mil.
Revenue was 37.167 + 31.56 + 38.506 + 48.561 = $155.8 Mil.
Gross Profit was 24.38 + 20.585 + 26.052 + 30.261 = $101.3 Mil.
Total Current Assets was $203.7 Mil.
Total Assets was $301.8 Mil.
Property, Plant and Equipment(Net PPE) was $83.2 Mil.
Depreciation, Depletion and Amortization(DDA) was $5.2 Mil.
Selling, General, & Admin. Expense(SGA) was $142.8 Mil.
Total Current Liabilities was $48.0 Mil.
Long-Term Debt & Capital Lease Obligation was $195.4 Mil.
Net Income was -16.202 + -20.542 + -29.273 + -16.745 = $-82.8 Mil.
Non Operating Income was -3.037 + 2.902 + -4.158 + 1.343 = $-3.0 Mil.
Cash Flow from Operations was -11.152 + -8.148 + -31.511 + -28.24 = $-79.1 Mil.
Total Receivables was $41.0 Mil.
Revenue was 46.524 + 43.813 + 38.245 + 41.19 = $169.8 Mil.
Gross Profit was 30.079 + 28.165 + 26.04 + 27.454 = $111.7 Mil.
Total Current Assets was $142.0 Mil.
Total Assets was $209.4 Mil.
Property, Plant and Equipment(Net PPE) was $61.0 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.4 Mil.
Selling, General, & Admin. Expense(SGA) was $130.8 Mil.
Total Current Liabilities was $41.5 Mil.
Long-Term Debt & Capital Lease Obligation was $182.1 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(50.838 / 155.794) / (41.049 / 169.772)
=0.326316 / 0.241789
=1.3496

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(111.738 / 169.772) / (101.278 / 155.794)
=0.658165 / 0.650076
=1.0124

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (203.695 + 83.152) / 301.838) / (1 - (142.041 + 61.049) / 209.359)
=0.049666 / 0.029944
=1.6586

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=155.794 / 169.772
=0.9177

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4.404 / (4.404 + 61.049)) / (5.183 / (5.183 + 83.152))
=0.067285 / 0.058674
=1.1468

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(142.81 / 155.794) / (130.777 / 169.772)
=0.916659 / 0.77031
=1.19

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((195.366 + 48.016) / 301.838) / ((182.063 + 41.471) / 209.359)
=0.806333 / 1.067707
=0.7552

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-82.762 - -2.95 - -79.051) / 301.838
=-0.002521

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Establishment Labs Holdings has a M-score of -1.91 suggests that the company is unlikely to be a manipulator.


Establishment Labs Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Establishment Labs Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Establishment Labs Holdings (Establishment Labs Holdings) Business Description

Traded in Other Exchanges
Address
Coyol Free Zone, Building B15 and 25, Alajuela, CRI
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Executives
Nicholas Sheridan Lewin director, 10 percent owner 3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Raj Denhoy officer: Chief Financial Officer C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Dennis E Condon director 811 ALSTON RD, SANTA BARBARA CA 93108
Leslie Gillin director C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Paul D. Rodio officer: Chief Operating Officer C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Samuel Ross Mansbach other: GC & Chief Compliance Officer C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Jw Asset Management, Llc 10 percent owner, other: See Footnote(1) 1051 N VENETIAN DRIVE, MIAMI BEACH FL 33139
Bryan Slotkin director C/O MOTIVA USA,.LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Ann Custin director C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Edward J Schutter director C/O FIRST HORIZON PHARMACEUTICAL CORP, 6195 SHILOH ROAD, ALPHARETTA GA 30005
Lisa Gersh director C/O HASBRO, INC., 1011 NEWPORT AVENUE, PAWTUCKET RI 02861
Mezerville Roberto De officer: Chief Technology Officer C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Renee Gaeta officer: Chief Financial Officer C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Pratip Dastidar officer: Head of Global Operations 150 PEABODY PLACE, MEMPHIS TN 38103
Santos Salvador Dada officer: Chief Operating Officer C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958